Mortality among persons receiving tuberculosis treatment in Itezhi-Tezhi District of Zambia: A retrospective cohort study.

Itezhi-Tezhi District in southern Zambia has been reporting tuberculosis (TB) mortality rates that are fourfold higher than the national average of six percent. We conducted a retrospective cohort study to establish the demographic and clinical characteristics associated with mortality among persons...

Full description

Bibliographic Details
Main Authors: Eutra Chaaba, Josphat Bwembya, Eness Nyambe, Ramya Kumar, Ibou Thior, Kaminsa Seraphine, Gershom Chongwe, Vimbai Makwambeni, Victoria Musonda, Pauline Kasese-Chanda, Alwyn Mwinga
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLOS Global Public Health
Online Access:https://doi.org/10.1371/journal.pgph.0001234
_version_ 1827826621224058880
author Eutra Chaaba
Josphat Bwembya
Eness Nyambe
Ramya Kumar
Ibou Thior
Kaminsa Seraphine
Gershom Chongwe
Vimbai Makwambeni
Victoria Musonda
Pauline Kasese-Chanda
Alwyn Mwinga
author_facet Eutra Chaaba
Josphat Bwembya
Eness Nyambe
Ramya Kumar
Ibou Thior
Kaminsa Seraphine
Gershom Chongwe
Vimbai Makwambeni
Victoria Musonda
Pauline Kasese-Chanda
Alwyn Mwinga
author_sort Eutra Chaaba
collection DOAJ
description Itezhi-Tezhi District in southern Zambia has been reporting tuberculosis (TB) mortality rates that are fourfold higher than the national average of six percent. We conducted a retrospective cohort study to establish the demographic and clinical characteristics associated with mortality among persons under treatment for TB in Itezhi-Tezhi District, as well as the likely causes and time to death. We reviewed medical records for persons with TB registered in 19 public health facilities in Itezhi-Tezhi District between January 2015 and December 2018. Of the 506 persons with TB registered in the study period, 426 were included in the analysis. Of these, 71 (16.7%) died before completing treatment. The overall mortality rate was 31.8 per 1,000 person-months of observation. Most of the deaths (53 [74.7%]) occurred in the first month of treatment (median: 16 days; interquartile range: 5-52 days). In a multivariate Cox regression model, type of TB was found to be an independent predictor of mortality while on TB treatment. The risk of dying was more than twice higher for persons with clinically diagnosed PTB compared to those with bacteriologically confirmed PTB (adjusted hazard ratio = 2.2, 95% CI: 1.4-3.6). In a sub-analysis of persons with clinically diagnosed PTB, persons with TB who were on a community-based DOT plan were more than twice more likely to die compared to those on facility-based DOT plan (adjusted hazard ratio = 2.21, 95% CI: 1.1-4.8). Common likely causes of death were pulmonary TB disease (66.0%), anemia (12.8%), cardiac failure (4.3%), pneumocystis jiroveci pneumonia (4.3%), and gastroenteritis (4.2%). These findings show that most deaths occurred during the first month of treatment. Clinical evaluation at initiation of anti-TB treatment and during follow-up care, especially in persons with clinically diagnosed PTB, should include screening and treatment of other conditions.
first_indexed 2024-03-12T03:14:15Z
format Article
id doaj.art-8358501104af4386a766dee9e174b32c
institution Directory Open Access Journal
issn 2767-3375
language English
last_indexed 2024-03-12T03:14:15Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLOS Global Public Health
spelling doaj.art-8358501104af4386a766dee9e174b32c2023-09-03T14:12:38ZengPublic Library of Science (PLoS)PLOS Global Public Health2767-33752023-01-0132e000123410.1371/journal.pgph.0001234Mortality among persons receiving tuberculosis treatment in Itezhi-Tezhi District of Zambia: A retrospective cohort study.Eutra ChaabaJosphat BwembyaEness NyambeRamya KumarIbou ThiorKaminsa SeraphineGershom ChongweVimbai MakwambeniVictoria MusondaPauline Kasese-ChandaAlwyn MwingaItezhi-Tezhi District in southern Zambia has been reporting tuberculosis (TB) mortality rates that are fourfold higher than the national average of six percent. We conducted a retrospective cohort study to establish the demographic and clinical characteristics associated with mortality among persons under treatment for TB in Itezhi-Tezhi District, as well as the likely causes and time to death. We reviewed medical records for persons with TB registered in 19 public health facilities in Itezhi-Tezhi District between January 2015 and December 2018. Of the 506 persons with TB registered in the study period, 426 were included in the analysis. Of these, 71 (16.7%) died before completing treatment. The overall mortality rate was 31.8 per 1,000 person-months of observation. Most of the deaths (53 [74.7%]) occurred in the first month of treatment (median: 16 days; interquartile range: 5-52 days). In a multivariate Cox regression model, type of TB was found to be an independent predictor of mortality while on TB treatment. The risk of dying was more than twice higher for persons with clinically diagnosed PTB compared to those with bacteriologically confirmed PTB (adjusted hazard ratio = 2.2, 95% CI: 1.4-3.6). In a sub-analysis of persons with clinically diagnosed PTB, persons with TB who were on a community-based DOT plan were more than twice more likely to die compared to those on facility-based DOT plan (adjusted hazard ratio = 2.21, 95% CI: 1.1-4.8). Common likely causes of death were pulmonary TB disease (66.0%), anemia (12.8%), cardiac failure (4.3%), pneumocystis jiroveci pneumonia (4.3%), and gastroenteritis (4.2%). These findings show that most deaths occurred during the first month of treatment. Clinical evaluation at initiation of anti-TB treatment and during follow-up care, especially in persons with clinically diagnosed PTB, should include screening and treatment of other conditions.https://doi.org/10.1371/journal.pgph.0001234
spellingShingle Eutra Chaaba
Josphat Bwembya
Eness Nyambe
Ramya Kumar
Ibou Thior
Kaminsa Seraphine
Gershom Chongwe
Vimbai Makwambeni
Victoria Musonda
Pauline Kasese-Chanda
Alwyn Mwinga
Mortality among persons receiving tuberculosis treatment in Itezhi-Tezhi District of Zambia: A retrospective cohort study.
PLOS Global Public Health
title Mortality among persons receiving tuberculosis treatment in Itezhi-Tezhi District of Zambia: A retrospective cohort study.
title_full Mortality among persons receiving tuberculosis treatment in Itezhi-Tezhi District of Zambia: A retrospective cohort study.
title_fullStr Mortality among persons receiving tuberculosis treatment in Itezhi-Tezhi District of Zambia: A retrospective cohort study.
title_full_unstemmed Mortality among persons receiving tuberculosis treatment in Itezhi-Tezhi District of Zambia: A retrospective cohort study.
title_short Mortality among persons receiving tuberculosis treatment in Itezhi-Tezhi District of Zambia: A retrospective cohort study.
title_sort mortality among persons receiving tuberculosis treatment in itezhi tezhi district of zambia a retrospective cohort study
url https://doi.org/10.1371/journal.pgph.0001234
work_keys_str_mv AT eutrachaaba mortalityamongpersonsreceivingtuberculosistreatmentinitezhitezhidistrictofzambiaaretrospectivecohortstudy
AT josphatbwembya mortalityamongpersonsreceivingtuberculosistreatmentinitezhitezhidistrictofzambiaaretrospectivecohortstudy
AT enessnyambe mortalityamongpersonsreceivingtuberculosistreatmentinitezhitezhidistrictofzambiaaretrospectivecohortstudy
AT ramyakumar mortalityamongpersonsreceivingtuberculosistreatmentinitezhitezhidistrictofzambiaaretrospectivecohortstudy
AT ibouthior mortalityamongpersonsreceivingtuberculosistreatmentinitezhitezhidistrictofzambiaaretrospectivecohortstudy
AT kaminsaseraphine mortalityamongpersonsreceivingtuberculosistreatmentinitezhitezhidistrictofzambiaaretrospectivecohortstudy
AT gershomchongwe mortalityamongpersonsreceivingtuberculosistreatmentinitezhitezhidistrictofzambiaaretrospectivecohortstudy
AT vimbaimakwambeni mortalityamongpersonsreceivingtuberculosistreatmentinitezhitezhidistrictofzambiaaretrospectivecohortstudy
AT victoriamusonda mortalityamongpersonsreceivingtuberculosistreatmentinitezhitezhidistrictofzambiaaretrospectivecohortstudy
AT paulinekasesechanda mortalityamongpersonsreceivingtuberculosistreatmentinitezhitezhidistrictofzambiaaretrospectivecohortstudy
AT alwynmwinga mortalityamongpersonsreceivingtuberculosistreatmentinitezhitezhidistrictofzambiaaretrospectivecohortstudy